The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 13, 2018

Filed:

Jul. 29, 2011
Applicants:

Leslie S. Johnson, Darnestown, MD (US);

Ling Huang, Bethesda, MD (US);

Godfrey Jonah Anderson Rainey, Kensington, MD (US);

Inventors:

Leslie S. Johnson, Darnestown, MD (US);

Ling Huang, Bethesda, MD (US);

Godfrey Jonah Anderson Rainey, Kensington, MD (US);

Assignee:

MacroGenics, Inc., Rockville, MD (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/30 (2006.01); C07K 16/28 (2006.01); A61K 38/16 (2006.01); C07K 14/315 (2006.01); C07K 16/32 (2006.01); C07K 16/44 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61K 38/164 (2013.01); C07K 14/315 (2013.01); C07K 16/283 (2013.01); C07K 16/2803 (2013.01); C07K 16/2809 (2013.01); C07K 16/2851 (2013.01); C07K 16/32 (2013.01); C07K 16/44 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/35 (2013.01); C07K 2317/52 (2013.01); C07K 2317/626 (2013.01); C07K 2317/64 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C07K 2319/31 (2013.01); C07K 2319/70 (2013.01);
Abstract

Diabody molecules and uses thereof in the treatment of a variety of diseases and disorders, including immunological disorders, infectious disease, intoxication and cancers are disclosed. The diabody molecules comprise two polypeptide chains that associate to form at least two epitope binding sites, which may recognize the same or different epitopes on the same or differing antigens. Additionally, the antigens may be from the same or different molecules. The individual polypeptide chains of the diabody molecule may be covalently bound through non-peptide bond covalent bonds, such as disulfide bonding of cysteine residues located within each polypeptide chain. The diabody molecules may further comprise an Fc region, which allows antibody-like functionality to be engineered into the molecule.


Find Patent Forward Citations

Loading…